Comment on Dumortier et al. Before Starting Sodium–Glucose Cotransporter 2 Inhibitors, the Clinical Stage of Peripheral Artery Disease Should Be Defined

Adélaïde Guézais, Marjolaine Talbot, Guillaume Mahé

Open source

DOI
10.2337/dc26-0792
Published
2026-07-20
Container
Diabetes Care
Publisher
American Diabetes Association
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2337/dc26-0792,
  title = {Comment on Dumortier et al. Before Starting Sodium–Glucose Cotransporter 2 Inhibitors, the Clinical Stage of Peripheral Artery Disease Should Be Defined},
  author = {Adélaïde Guézais and Marjolaine Talbot and Guillaume Mahé},
  year = {2026},
  journal = {Diabetes Care},
  doi = {10.2337/dc26-0792},
  url = {https://doi.org/10.2337/dc26-0792}
}

RIS

TY  - JOUR
TI  - Comment on Dumortier et al. Before Starting Sodium–Glucose Cotransporter 2 Inhibitors, the Clinical Stage of Peripheral Artery Disease Should Be Defined
AU  - Adélaïde Guézais
AU  - Marjolaine Talbot
AU  - Guillaume Mahé
PY  - 2026
JO  - Diabetes Care
DO  - 10.2337/dc26-0792
UR  - https://doi.org/10.2337/dc26-0792
ER  - 

APA

Guézais, A., Talbot, M., & Mahé, G. (2026). Comment on Dumortier et al. Before Starting Sodium–Glucose Cotransporter 2 Inhibitors, the Clinical Stage of Peripheral Artery Disease Should Be Defined. Diabetes Care. https://doi.org/10.2337/dc26-0792

Source records